|
|
|
|
Vol. 12, Issue 1, 171-184, January 2001
Center for Neurologic Diseases, Department of Medicine,
Brigham and Women's Hospital, Harvard Medical School, Boston,
Massachusetts 02115
How tau mutations lead to neurodegeneration is unknown but may be
related to altered microtubule binding properties of mutant tau
protein. The tendency for the mutations to cluster around the
microtubule-binding domain of tau or to alter the ratios of those
splice isoforms that affect binding supports the view that the
tau/microtubule interaction is critical and finely regulated. In cells
transfected with both mutant and wild-type tau isoforms fused to either
yellow fluorescent protein or cyan fluorescent protein we can observe
tau fusion proteins that differ by a single amino acid or by the
inclusion or exclusion of exon 10. With coexpression of mutant and
wild-type tau, the mutant isoform appears diffuse throughout the
cytoplasm; however, when mutant tau is expressed alone, it appears
mostly bound to the microtubules. Dual imaging of the three- and
four-repeat tau isoforms indicated that the expression of four-repeat
tau displaced three-repeat tau from the microtubules. These results
suggest that altered kinetic competition among the isoforms for
microtubule binding could be a disease precipitant.
Corresponding author. E-mail address:
kosik{at}cnd.bwh.harvard.edu.
This article has been cited by other articles:
![]() |
S. Konzack, E. Thies, A. Marx, E.-M. Mandelkow, and E. Mandelkow Swimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons J. Neurosci., September 12, 2007; 27(37): 9916 - 9927. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Qiang, W. Yu, A. Andreadis, M. Luo, and P. W. Baas Tau protects microtubules in the axon from severing by katanin. J. Neurosci., March 22, 2006; 26(12): 3120 - 3129. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Liazoghli, S. Perreault, K. D. Micheva, M. Desjardins, and N. Leclerc Fragmentation of the Golgi Apparatus Induced by the Overexpression of Wild-Type and Mutant Human Tau Forms in Neurons Am. J. Pathol., May 1, 2005; 166(5): 1499 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Farah, D. Liazoghli, S. Perreault, M. Desjardins, A. Guimont, A. Anton, M. Lauzon, G. Kreibich, J. Paiement, and N. Leclerc Interaction of Microtubule-associated Protein-2 and p63: A NEW LINK BETWEEN MICROTUBULES AND ROUGH ENDOPLASMIC RETICULUM MEMBRANES IN NEURONS J. Biol. Chem., March 11, 2005; 280(10): 9439 - 9449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Halverson, J. Lewis, S. Frausto, M. Hutton, and N. A. Muma Tau Protein Is Cross-Linked by Transglutaminase in P301L Tau Transgenic Mice J. Neurosci., February 2, 2005; 25(5): 1226 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhu, K. S. Kosik, T. E. Meigs, V. Yanamadala, and B. M. Denker G{alpha}12 Directly Interacts with PP2A: EVIDENCE FOR G{alpha}12-STIMULATED PP2A PHOSPHATASE ACTIVITY AND DEPHOSPHORYLATION OF MICROTUBULE-ASSOCIATED PROTEIN, Tau J. Biol. Chem., December 31, 2004; 279(53): 54983 - 54986. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. VENTI, T. GIORDANO, P. EDER, A. I. BUSH, D. K. LAHIRI, N. H. GREIG, and J. T. ROGERS The Integrated Role of Desferrioxamine and Phenserine Targeted to an Iron-Responsive Element in the APP-mRNA 5'-Untranslated Region Ann. N.Y. Acad. Sci., December 1, 2004; 1035(1): 34 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. AVILA, J. J. LUCAS, M. PEREZ, and F. HERNANDEZ Role of Tau Protein in Both Physiological and Pathological Conditions Physiol Rev, April 1, 2004; 84(2): 361 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shimura, D. Schwartz, S. P. Gygi, and K. S. Kosik CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival J. Biol. Chem., February 6, 2004; 279(6): 4869 - 4876. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hernandez, M. Perez, J. J. Lucas, A. M. Mata, R. Bhat, and J. Avila Glycogen Synthase Kinase-3 Plays a Crucial Role in Tau Exon 10 Splicing and Intranuclear Distribution of SC35: IMPLICATIONS FOR ALZHEIMER'S DISEASE J. Biol. Chem., January 30, 2004; 279(5): 3801 - 3806. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Stanford, C. E. Shepherd, G. M. Halliday, W. S. Brooks, P. W. Schofield, H. Brodaty, R. N. Martins, J. B. J. Kwok, and P. R. Schofield Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia Brain, April 1, 2003; 126(4): 814 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. DeTure, L.-w. Ko, C. Easson, and S.-H. Yen tau Assembly in Inducible Transfectants Expressing Wild-Type or FTDP-17 tau Am. J. Pathol., November 1, 2002; 161(5): 1711 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Stamer, R. Vogel, E. Thies, E. Mandelkow, and E.-M. Mandelkow Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress J. Cell Biol., March 18, 2002; 156(6): 1051 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kalbfuss, S. A. Mabon, and T. Misteli Correction of Alternative Splicing of Tau in Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 J. Biol. Chem., November 9, 2001; 276(46): 42986 - 42993. [Abstract] [Full Text] [PDF] |
||||